艾博生物医药（杭州）有限公司

艾博生物医药（杭州）有限公司是一家成立于2003年的高科技生物技术外资企业，坐落于国家级开发区――杭州经济技术开发区（下沙）医药园区内，是杭州经济技术开发区2003年重点引进的外商独资企业，地理位置优越，配套设施齐全，交通便利。公司占地面积近百亩，建筑面积达3万平方米，由国外著名设计单位进行总体设计，风格独特，环境优雅，为员工提供了舒适的工作环境，为花园式工厂的典范。
公司主要从事研究、开发、生产体外诊断试剂；销售本公司生产的产品，并提供技术服务。公司投资总额2998万美元，注册资本1200万美元。公司产品已获美国FDA注册和欧洲CE注册，主导产品为快速诊断产品，包括妊娠检测、传染病检测、毒品检测、肿瘤标志物检测和心脏病标志物检测等五大系列，畅销全球100多个国家和地区，在北美、欧洲、以色列、澳大利亚、日本、新西兰等国际市场上占有较高的份额。
公司拥有强大的科研开发和技术创新能力，在胶体金、乳胶等标记技术、单克隆抗体，多克隆抗体，基因重组抗原，合成抗原等生物原料技术，以及免疫层析技术等前沿生物领域的研究方面处于国内领先水平。公司已通过了国家食品药品监督管理局的GMP认证和欧洲TÜV的ISO13485：2003质量管理体系认证并被国家发展和改革委员会认定为国家高技术产业化示范工程项目。

艾博公司
愿景：为全人类的健康提供世界级的产品。
使命：打造全球体外快速诊断试剂顶尖的研发生产中心。

IMI集团
愿景：提供人们能在家中呵护自己健康生活的创新产品。
使命：成为女性健康和慢性疾病自我监控领域创新产品的领导供应商。

公司提倡以下行为能力素质：信任他人并赢得信任；尊重他人；激励他人；坚持高标准，严高求，下定必胜的决心，积极进取，关注大局。

公司拥有完善的制度，轻松和谐的工作环境，系统的员工培训发展。
我们期待优秀的您的加盟，携手共进，奏响工作和生活的新篇章。感谢您对我们公司的关注！

Established in 2003, ABON Biopharm (Hangzhou) Co., Ltd is located in oneof the most prestigious economy and technology development zones inChina: the Hangzhou City Economy and Technology Development Zone.Designated as a fully owned entity of foreign investors, the ABONBiopharm(Hangzhou) Co., Ltd has been recognized by the city governmentas the most important foreign investment project in the area ofBiotechnology in the city of Hangzhou.
The manufacture facility was designed by a San Diego, Californiaarchitect firm, with garden-like building areas of approximately 30,000sq. meters or 300,000 sq. ft. divided into manufacturing areas, R&Dlabs, offices and multifunctional supporting facilities, such as amultifunctional auditorium for 300 persons. There are over 900 employeescurrently working in this state-of-the-art in vitro diagnostic (IVD)device manufacturing facility equipped with all the necessary amenitiesof a modern IVD manufacturing facility.
The designing and building of ABON Biopharm manufacturing facility waswith global visions to comply with every quality system requirementestablished with various countries and regions. ABON Biopharm has beenregistered with the U. S. FDA as a medical device establishment. It alsohas ISO 13485:2003 and the Japanese jGMP certifications as an IVD devicemanufacturing establishment. Recently the facility passed the ChineseGMP inspection. It has also registered with the regulatory agencies ofCanada and Australia as a qualified medical device manufacturer tosupply products to these countries.
ABON Biopharm is thriving on innovative research, fast productdevelopment, efficient manufacturing and high volume marketing and salesof the lateral flow rapid IVD products based on an impeccable businessphilosophy of high quality, competitive price, flexible customer OEMproduct design and superior customer service. The ABON lateral flowrapid IVD products lines include tests for drugs of abuse, infectiousdisease, fertility, tumor markers, and cardiac markers. Many of theseproducts are FDA 510K cleared and/or bear CE Mark. They are nowcommanding very good market shares in the United States, Canada,European Union, Israel, Australia, New Zealand and Japan markets.
Since April 2006, ABON Biopharm manufacturing facility, together withits sister company Innovacon Inc. located in San Diego, California,U.S.A., has been acquired by the Inverness Medical Innovations (IMI). AsABON Biopharm is transitioning into the Inverness business family, it ispositioning itself to become the global manufacturing center for the IMIorganization.
In the near future, ABON Biopharm is poised to become the best and thelargest as well as the most efficient low cost and high quality lateralflow immunoassay test producer for the world.